Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
about
The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse modelOptimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccinesBiosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient micePrediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model.Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cellsTowards universal structure-based prediction of class II MHC epitopes for diverse allotypes.Alternatively spliced transcripts of the thymus-specific protease PRSS16 are differentially expressed in human thymus.Celiac disease: a model autoimmune disease with gene therapy applications.Peptide immunotherapy for allergic disease.Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MSRegister shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletionPeptide-based therapeutic vaccines for allergic and autoimmune diseases.Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.Asparaginyl endopeptidase: case history of a class II MHC compartment protease.Spontaneous recovery from early glomerular inflammation is associated with resistance to anti-GBM glomerulonephritis: tolerance and autoimmune tissue injury.Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies.Antigen-specific immunotherapy of autoimmune and allergic diseasesSelection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice.Induction of murine thyroiditis by a non dominant E(k)-restricted peptide of human thyroglobulin.Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.Altered immunogenicity of isoaspartate containing proteins.Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptide.ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.
P2860
Q24795875-43332698-E72F-43DF-B774-FC7154C94BCDQ26738680-E24BFC33-3FFB-4D46-84CA-72A79712064DQ28513876-12443CFB-547D-43AD-8334-406AC3556E0AQ33525382-0F4749F8-C341-4F5B-9E3D-F29ADF620863Q33557177-906A5A50-FE83-4F8A-B52B-8EFF5AE867D0Q33781091-A5E7B4B0-AA38-47E3-AD7F-13F92809327FQ34375581-48441111-29C9-42D6-A19A-8222F6793DC1Q35122155-A0898C64-E2B3-433A-BC7A-3E4221F151B2Q35164800-FE3CEF3A-49F2-4577-BD01-FDBE9BDD9BF4Q35179832-4D70F23B-C5F0-4EDF-A54B-42733130897EQ35669113-3DBB82DE-1D7C-4C9C-B737-A221A7F371F3Q36090197-AAD9E071-499D-4522-BDFE-4E00408A9E49Q36218461-5B37367D-BE53-4EC2-BE85-0DBDB568F8D9Q36266494-267DCE87-E835-436F-9A08-A31AF6841ACDQ36961105-961231F5-814D-4C04-89CD-DCE1102F5A43Q37343069-76C5F542-8D87-48A4-B7DC-432669AD2980Q37754572-508D2578-7736-44F3-A1BB-9D66065CCD33Q37790023-786F340E-0EDB-4585-872E-B1168CABCE22Q39038768-B7BDD0EF-4B30-4D70-955D-815D2CC7351FQ39740168-D19F59CA-B2B5-42DB-8DC8-B940A4B1D361Q45018413-E91EC49F-1BF2-4F24-AEE1-17A5E5AD76DCQ48003010-2CE175FF-2531-41DE-A6C8-CD241427B2C0Q53272970-77375C2A-5B2D-459B-82CD-94F7DD98B177Q53798547-0A94138F-733C-49DE-B00E-5A48DBF4FB04Q54524412-2809D1DE-FCCB-415C-AE7F-070C0E212122Q55399628-827F94C2-A09B-4D45-886B-D6EDCA6D9620
P2860
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@en
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@nl
type
label
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@en
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@nl
prefLabel
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@en
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@nl
P2093
P2860
P356
P1433
P1476
Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
@en
P2093
David C Wraith
Nicholas J Viner
Pauline A Lowrey
Philip Matharu
Stephen M Anderton
P2860
P304
P356
10.1038/NI756
P407
P577
2002-01-14T00:00:00Z